• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ROTABLATOR ROTATIONAL ATHERECTOMY SYSTEM; CATHETER, CORONARY, ATHERECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ROTABLATOR ROTATIONAL ATHERECTOMY SYSTEM; CATHETER, CORONARY, ATHERECTOMY Back to Search Results
Device Problem Failure to Advance (2524)
Event Date 01/29/2024
Event Type  Injury  
Event Description
Agent ide study it was reported that reduced blood flow occurred.On december 10th, 2021, a target lesion in the mid left anterior descending artery (lad) was treated with balloon angioplasty using a 2.50 x 30mm agent dcb.On january 29th, 2024 the subject presented with 90% restenosis at the mid lad.The target lesion was first treated using a non-boston scientific balloon after this, rotational atherectomy was performed using a 1.50mm rotapro burr, however the rotapro burr was unable to be advanced into the lesion.At this point the repeated angiography revealed no reflow in the lad for which further rotablation was not performed.Post this, the lesion was treated with a 2.50 x 10mm wolverine cutting balloon which was also unable to cross the stent distally.Finally, a 2.50 x 15mm nc emerge balloon was used inflated in the entire stented segment.Post which, the ivus revealed luminal gain and no edge complication, 20% residual stenosis with timi flow of 3.On january 31st, 2024, the subject was stable without any chest pain revealing stable ekg with normal evolution of mi and the subject was discharged with clopidogrel, warfarin, imdur, metop, and crestor, followed by cardiac rehabilitation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ROTABLATOR ROTATIONAL ATHERECTOMY SYSTEM
Type of Device
CATHETER, CORONARY, ATHERECTOMY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC LTD
model farm road
cork
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18913670
MDR Text Key337775334
Report Number2124215-2024-15834
Device Sequence Number1
Product Code MCX
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/15/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/15/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/21/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age84 YR
Patient SexFemale
-
-